Biotronik enrols first patients for Acticor CRT-DX system trial

By NS Medical Staff Writer

02 Aug 21

The company will enrol up to 400 HF patients with paroxysmal, persistent and long-standing persistent AF, at up…

DevicesCardiovascular

Orchestra BioMed announces clinical data showing BP reduction in MODERATO II Control patients after crossover to BackBeat CNT

By NS Medical Staff Writer

02 Aug 21

Orchestra BioMed is a biomedical innovation company focused on developing transformative therapeutic products for large unmet needs in…

DevicesCardiovascular

Biofourmis gets FDA breakthrough device status for digital therapeutic to treat heart failure

By NS Medical Staff Writer

30 Jul 21

BiovitalsHF will help boost the guideline-directed use of heart failure medications to manage patients in combination with traditional…

DevicesCardiovascular

Paragonix initiates GUARDIAN-HEART study in paediatric patients

By NS Medical Staff Writer

29 Jul 21

The paediatric registry collects real-world data and determines the impact of advanced preservation methods compared to standard methods

DevicesCardiovascular

Medtronic Announces FDA Clearance and Results of Artificial Intelligence Algorithms for Cardiac Monitoring

By NS Medical Staff Writer

29 Jul 21

AI Algorithms Enhance LINQ II™ Insertable Cardiac Monitor Diagnostic Accuracy for Improved Management of Patients

DevicesCardiovascular

CorMatrix Cardiovascular completes growth financing led by Jam Capital Partners

By NS Medical Staff Writer

28 Jul 21

Leading Developer of Regenerative Cardiovascular Products to Complete FDA Clinical Trial and Advance Other Technologies in Treatment of…

DevicesCardiovascular

Boston Scientific’s WATCHMAN FLX LAAC device meets 24-month endpoint in study

By NS Medical Staff Writer

22 Jul 21

The trial is designed to assess the safety and efficacy of the next-generation WATCHMAN FLX LAAC device to…

DevicesCardiovascular

Ancora Heart wins $80m funding for AccuCinch ventricular restoration system trial

By NS Medical Staff Writer

20 Jul 21

The randomised and international clinical trial will enroll around 400 patients at up to 80 centres across the…

DevicesCardiovascular

CARMAT achieves first commercial implant of artificial heart in Italy

By NS Medical Staff Writer

19 Jul 21

The company received CE marking for its artificial heart as a bridge to transplant in December last year

DevicesCardiovascular

CORCYM enrolls first patient in MANTRA Study

By NS Medical Staff Writer

19 Jul 21

The first patient was implanted in Italy, at Città di Lecce Hospital with a Bicarbon aortic mechanical valve

DevicesCardiovascular